RecruitingNCT03848962

Collection and Distribution of Biospecimens for Novel Research Uses

iSpecimen Network Protocol: Collection and Distribution of Remnant and Research Use Only Biospecimens for Novel Research Uses


Sponsor

iSpecimen Inc

Enrollment

10,000 participants

Start Date

Jun 30, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").


Eligibility

Min Age: 1 MonthMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with autoimmune diseases, blood disease, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Month to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

iSpecimen

Huntsville, Alabama, United States

iSpecimen

Lexington, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03848962


Related Trials